HM Payson & Co’s Merck MRK Stock Holding History

HM Payson & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.2M	Sell	172,406 -17,334	-9%	-$2.03M	0.29%	65
2026 Q1	$22.8M	Buy	189,740 +2,262	+1%	+$261K	0.33%	64
2025 Q4	$19.7M	Sell	187,478 -3,712	-2%	-$348K	0.28%	68
2025 Q3	$16M	Sell	191,190 -6,181	-3%	-$509K	0.23%	68
2025 Q2	$15.6M	Sell	197,371 -13,573	-6%	-$1.08M	0.25%	66
2025 Q1	$18.9M	Sell	210,944 -106,176	-33%	-$9.91M	0.33%	60
2024 Q4	$31.5M	Sell	317,120 -333,686	-51%	-$34.4M	0.54%	51
2024 Q3	$73.9M	Buy	650,806 +93,401	+17%	+$11.1M	1.27%	23
2024 Q2	$69M	Buy	557,405 +3,056	+0.6%	+$394K	1.25%	28
2024 Q1	$73.1M	Sell	554,349 -16,175	-3%	-$1.99M	1.36%	24
2023 Q4	$62.2M	Buy	570,524 +46,666	+9%	+$4.84M	1.29%	22
2023 Q3	$53.9M	Buy	523,858 +241,222	+85%	+$26M	1.26%	25
2023 Q2	$32.6M	Buy	282,636 +9,177	+3%	+$1.04M	0.73%	45
2023 Q1	$29.1M	Buy	273,459 +12,535	+5%	+$1.35M	0.7%	46
2022 Q4	$28.9M	Buy	260,924 +50,527	+24%	+$5.16M	0.72%	46
2022 Q3	$18.1M	Sell	210,397 -7,468	-3%	-$667K	0.5%	51
2022 Q2	$19.9M	Sell	217,865 -2,399	-1%	-$213K	0.51%	55
2022 Q1	$18.1M	Sell	220,264 -809	-0.4%	-$63.8K	0.41%	58
2021 Q4	$16.9M	Sell	221,073 -13,180	-6%	-$1.05M	0.37%	63
2021 Q3	$17.6M	Sell	234,253 -64,410	-22%	-$4.9M	0.43%	58
2021 Q2	$23.2M	Sell	298,663 -21,612	-7%	-$1.61M	0.57%	53
2021 Q1	$23.6M	Sell	320,275 -10,069	-3%	-$743K	0.63%	49
2020 Q4	$25.8M	Sell	330,344 -4,098	-1%	-$313K	0.71%	41
2020 Q3	$26.5M	Buy	334,442 +35,480	+12%	+$2.78M	0.82%	37
2020 Q2	$22.1M	Sell	298,962 -14,585	-5%	-$1.1M	0.74%	41
2020 Q1	$23M	Sell	313,547 -9,659	-3%	-$759K	0.9%	38
2019 Q4	$28M	Buy	323,206 +1,149	+0.4%	+$94.4K	0.9%	41
2019 Q3	$25.9M	Buy	322,057 +12,161	+4%	+$975K	0.91%	41
2019 Q2	$24.8M	Sell	309,896 -3,353	-1%	-$257K	0.89%	41
2019 Q1	$24.9M	Buy	313,249 +309,193	+7,623%	+$23.1M	0.95%	40
2018 Q4	$296K	Sell	4,056 -337,028	-99%	-$23.8M	0.87%	42
2018 Q3	$23.1M	Sell	341,084 -77,915	-19%	-$4.96M	1.03%	35
2018 Q2	$24.3M	Sell	418,999 -1,285	-0.3%	-$72.5K	1.04%	33
2018 Q1	$21.8M	Buy	420,284 +22,941	+6%	+$1.24M	0.9%	38
2017 Q4	$21.3M	Buy	397,343 +20,025	+5%	+$1.11M	0.86%	42
2017 Q3	$23.1M	Sell	377,318 -2,268	-0.6%	-$138K	0.99%	38
2017 Q2	$23.2M	Sell	379,586 -4,739	-1%	-$288K	1.05%	33
2017 Q1	$23.3M	Sell	384,325 -311	-0.1%	-$18.9K	1.06%	33
2016 Q4	$21.6M	Buy	384,636 +2,274	+0.6%	+$133K	1.03%	34
2016 Q3	$22.8M	Sell	382,362 -3,921	-1%	-$229K	1.11%	28
2016 Q2	$21.2M	Buy	386,283 +24,562	+7%	+$1.31M	1.06%	29
2016 Q1	$18.3M	Buy	361,721 +15,111	+4%	+$740K	0.95%	32
2015 Q4	$17.5M	Buy	346,610 +56,571	+20%	+$2.85M	0.9%	33
2015 Q3	$13.7M	Sell	290,039 -14,786	-5%	-$785K	0.74%	43
2015 Q2	$16.6M	Sell	304,825 -3,598	-1%	-$202K	0.82%	38
2015 Q1	$16.9M	Sell	308,423 -2,774	-0.9%	-$157K	0.85%	39
2014 Q4	$16.9M	Buy	311,197 +2,170	+0.7%	+$121K	0.83%	37
2014 Q3	$17.5M	Sell	309,027 -41,078	-12%	-$2.31M	0.9%	36
2014 Q2	$19.3M	Sell	350,105 -11,879	-3%	-$648K	0.99%	34
2014 Q1	$19.6M	Sell	361,984 -11,221	-3%	-$581K	1.04%	31
2013 Q4	$17.8M	Sell	373,205 -3,909	-1%	-$179K	0.95%	34
2013 Q3	$17.1M	Sell	377,114 -5,883	-2%	-$269K	0.99%	32
2013 Q2	$17M	Buy	+382,997	New	+$17.1M	1.02%	32

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

HM Payson & Co's MRK Position: Q2 2026 in Review

HM Payson & Co reduced its Merck (MRK) stake by 9.1% in Q2 2026, selling an estimated $2.03M and leaving 172,406 shares worth $22.2M. The position accounts for 0.29% of the portfolio, ranked #65.

HM Payson & Co first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $73.9M in Q3 2024. 1,533 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

HM Payson & Co held 172,406 shares of Merck worth $22.2M as of Q2 2026.
HM Payson & Co sold 17,334 Merck shares in Q2 2026, an estimated $2.03M.
Merck made up 0.29% of HM Payson & Co's portfolio in Q2 2026, its #65 holding.
HM Payson & Co first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
HM Payson & Co's Merck position peaked at $73.9M in Q3 2024.
1,533 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.